Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WuXi AppTec SVP Richard Soll On China’s Pharma Evolution: An Interview With PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

Soll talks about the transition of China’s top CRO from a preclinical play to an integrated services provider for innovative drug development.

Advertisement

Related Content

Fresh Off BMS Deal, Leading Chinese CRO WuXi PharmaTech Outlines Plan To Expand Biologics Business To Keep Pace With Big Pharma
Charles River Abandons WuXi PharmaTech Just Days Before Crucial Shareholder Votes On Planned Merger

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC084518

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel